ARTICLE | Company News
Advanced Viral, Northeastern University deal
March 3, 2008 8:00 AM UTC
Advanced Viral and the university partnered to identify the mechanism of action of the company’s lead compound, AVR118. The peptide nucleic acid-type immunomodulator is in Phase II testing to treat c...